MISSION Therapeutics' Grant - II Round

MISSION Therapeutics raised a round of funding on April 11, 2017. Investors include The Michael J. Fox Foundation.

MISSION Therapeutics is a private drug discovery company focused on elucidating and targeting the ubiquitin pathway to treat cancers and other diseases. The company is developing small molecule drugs …

Articles about MISSION Therapeutics' Grant - II Round: